Vnitr Lek 2020, 66(5):e43-e47 | DOI: 10.36290/vnl.2020.097

Liver transplantation as potential curative method in severe hemophilia A: case report and literature review

Pavel Polák1, Petr Smejkal1,2, Gabriela Romanová1, Jiřina Zavřelová1,2, Radomíra Hrdličková3, Šárka Blahutová3, Libuše Husová4,5, Marta Zvarová6, Miroslav Penka1,2
1 Oddělení klinické hematologie FN Brno, pracoviště Bohunice
2 Katedra laboratorních metod LF MU Brno
3 Krevní centrum FN Ostrava
4 Interní gastroenterologická klinika LF MU a FN Brno, pracoviště Bohunice
5 Centrum kardiovaskulární a transplantační chirurgie Brno
6 Oddělení klinické hematologie FN u sv. Anny Brno

The authors present clinical case of orthotopic liver transplantation for cirhosis due to chronic viral hepatitis C in a subject with severe hemophilia A. Preoperatively performed pharmacokinetic study with recombinant F VIII confirmed satisfactory in vivo recovery of 2.1 %. A bolus application of 52 units F VIII/kg body weight with target F VIII activity over 100.0 % was administred shortly before the transplantation started. Totally, 30 000 units of recombinant F VIII, 3 thrombocyte concentrates, 2 erythrocyte concentrates, 5 units of virally inactivated plasma, 1 unit of fresh frozen plasma and 3 500 antithrombin units were used. There were no perioperative or postoperative bleeding complications, F VIII substitution was stopped on postoperative day 3. The patient was discharged on twentieth postoperative day.

Keywords: hemophilia A, chronic viral hepatitis C, liver transplantation.

Published: August 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P, Smejkal P, Romanová G, Zavřelová J, Hrdličková R, Blahutová Š, et al.. Liver transplantation as potential curative method in severe hemophilia A: case report and literature review. Vnitr Lek. 2020;66(5):e43-47. doi: 10.36290/vnl.2020.097.
Download citation

References

  1. Matýšková M, Penka M. Hemofilie. Vnitř Lék 1991; 37: 397-403. Go to PubMed...
  2. Maier KP. Hepatitis‑Hepatitisfolgen. 6. Aufl. Bern: Verlag Hans Huber 2010, 457 s.
  3. Chorba TL, Holman RC, Clarke MJ, et al. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol 2001; 66: 229-240. Go to original source... Go to PubMed...
  4. Lewis JH, Bontempo FA, Spero JA, et al. Liver transplantation in a hemophiliac. N Engl J Med 1985; 312: 1189-1190. Go to original source... Go to PubMed...
  5. Norman JC, Lambilliotte JP, Kojima Y, et al. Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia. Science 1967; 158: 1060-1061. Go to original source... Go to PubMed...
  6. Webster WP, Zukoski CF, Hutchin P, et al. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol 1971; 220: 1147-1154. Go to original source... Go to PubMed...
  7. Stel HV, van der Kwast TH, Veerman EC. Detection of factor VIII/coagulant antigen in human liver tissue. Nature 1983; 303: 530-532. Go to original source... Go to PubMed...
  8. Webster WP, Mandel SR, Reddick RL, et al. Orthotopic liver transplantation in canine hemophilia B. Am J Physiol 1974; 226: 496-500. Go to original source... Go to PubMed...
  9. Kleeberger W, Rothamel T, Glockner S, et al. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR‑analysis. Hepatology 2002; 35: 110-116. Go to original source... Go to PubMed...
  10. Zanolini D, Merlin S, Feola M et, al. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Haematologica 2015; 100: 881-892. Go to original source... Go to PubMed...
  11. Groth CG, Ringdén O. Transplantation in relation to the treatment of inherited disease. XXXXXXXXX XXXX; XXX: XXX-XXX.
  12. Gupta E, Finn L, Johns G, et al. Correction of factor XI deficiency by liver transplantation. Blood Coagul Fibrinolysis 2015; 26: 961-963. Go to original source... Go to PubMed...
  13. Gallastegui N, Kimble EL, Harrington TJ. Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation. Haemophilia 2016; 22: e36-e79. Go to original source... Go to PubMed...
  14. Alonso Madrigal C, Dobón Rebollo M, Laredo de la Torre V, et al. Trasplante hepático en hemofilia A y enfermedad de von Willebrand tipo 3. Manejo perioperatorio y evolución postrasplante. Rev Esp Enferm Dig 2018; 110: 522-526. Go to original source... Go to PubMed...
  15. Suzuki Y, Kakisaka K, Matsumoto T, et al. Orthotopic liver transplantation for haemophilia A may not always lead to a phenotypic cure of haemophilia A: A case report. Haemophilia 2018; 24: e420-e422. Go to original source... Go to PubMed...
  16. Murthy V, Murray D, Hebballi S, et al. Outcome of liver transplantation in patients with hereditary bleeding disorders: a single centre UK experience. Haemophilia 2016; 22: e139-e144. Go to original source... Go to PubMed...
  17. Khakhar AK, Chan NG, Allan DS, et al. Catastrophic microangiopathy induced by high‑titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis. Haemophilia 2005; 11: 623-628. Go to original source... Go to PubMed...
  18. Srivastava A, Brewer AK, Mauser‑Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1-e47. Go to original source... Go to PubMed...
  19. Merlen C, Zourikian N, Bonnefoy A, et al. Effect of ABO blood group on haemostatic parameters in severe haemophilia A patients performing acute moderate‑intensity exercise. Blood Coagul Fibrinolysis 2018; 29: 626-635. Go to original source... Go to PubMed...
  20. Shapiro AD, Korth‑Bradley J, Poon MC. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia 2005; 11: 571-582. Go to original source... Go to PubMed...
  21. Björkman S, Folkesson A, Berntorp E. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting. Haemophilia 2007; 13: 2-8. Go to original source... Go to PubMed...
  22. Hazendonka HCAM, van Moorta I, Mathô RAA, et al. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play? Blood Rev 2018; 32: 265-271. Go to original source... Go to PubMed...
  23. Togashi J, Akamatsu N, Tanaka T, et al. Living donor liver transplantation for hemophilia with special reference to the management of perioperative clotting factor replacement. Liver Transplant 2016; 22: 366-370. Go to original source... Go to PubMed...
  24. Ragni MV, Devera ME, Roland ME, et al. Liver transplant outcomes in HIV+ haemophilic men. Haemophilia 2013; 19: 134-140. Go to original source... Go to PubMed...
  25. Yokoyama S, Bartlett A, Dar FS, et al. Outcome of liver transplantation for haemophilia. HPB (Oxford) 2011; 13: 40-45. Go to original source... Go to PubMed...
  26. Goldmann G, Zeitler H, Marquardt N, et al. Long‑term outcome of liver transplantation in HCV/HIV coinfected haemophilia patients. A single centre study of 10 patients. Hamostaseologie 2015; 35: 175-180. Go to original source... Go to PubMed...
  27. Park YK, Kim HC, Kim BW, et al. Auxiliary partial orthotopic liver transplantation as a treatment for hemophilia a: a case report. Transplant Proc 2015; 47: 161-164. Go to original source... Go to PubMed...
  28. Charvát J, Vychodil P, Adamec M, et al. Vyléčení těžké formy hemofilie A transplantací jater - kazuistika. Trombóza a hemostáza. Hradec Králové: HK Credit 2007, 114 s.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.